WAIPA ACT Tablets combine dihydroartemisinin 30 mg with piperaquine phosphate 225 mg in each tablet and are presented in a 12-tablet pack for malaria treatment use.
This product is an artemisinin-based combination therapy (ACT) oral tablet format commonly supplied as a fixed-dose antimalarial pack, with dosing typically structured across 3 days according to age and body weight guidance on pack labeling.
Use only as directed by a qualified healthcare professional, and complete the full prescribed course for appropriate malaria care.
